Literature DB >> 20132117

Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.

Elinore F McCance-Katz1, Lynn E Sullivan, Srikanth Nallani.   

Abstract

Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co-occurring medical and mental illnesses that require medication treatment. The abuse of illicit substances is also common in opioid-addicted individuals. These clinical realities place patients being treated with methadone and buprenorphine at risk for potentially toxic drug interactions. A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132117      PMCID: PMC3334287          DOI: 10.1111/j.1521-0391.2009.00005.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  78 in total

1.  Diazepam and methadone blood levels following concurrent administration of diazepam and methadone.

Authors:  K L Preston; R R Griffiths; E J Cone; W D Darwin; C W Gorodetzky
Journal:  Drug Alcohol Depend       Date:  1986-10       Impact factor: 4.492

2.  Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir.

Authors:  R Douglas Bruce; Frederick L Altice
Journal:  AIDS       Date:  2006-03-21       Impact factor: 4.177

Review 3.  Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view.

Authors:  A Sharma; B A Hamelin
Journal:  Curr Drug Metab       Date:  2003-04       Impact factor: 3.731

4.  Dextromethorphan-induced delirium and possible methadone interaction.

Authors:  Francis E Lotrich; Jules Rosen; Bruce G Pollock
Journal:  Am J Geriatr Pharmacother       Date:  2005-03

5.  Detection of alprazolam in three cases of methadone/benzodiazepine overdose.

Authors:  W O Rogers; M A Hall; R M Brissie; C A Robinson
Journal:  J Forensic Sci       Date:  1997-01       Impact factor: 1.832

6.  Interaction of methadone with didanosine and stavudine.

Authors:  P M Rainey; G Friedland; E F McCance-Katz; L Andrews; S M Mitchell; C Charles; P Jatlow
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

Review 7.  Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.

Authors:  Elinore F McCance-Katz
Journal:  Clin Infect Dis       Date:  2005-07-01       Impact factor: 9.079

Review 8.  Pharmacologic treatments for heroin and cocaine dependence.

Authors:  Herbert D Kleber
Journal:  Am J Addict       Date:  2003

9.  Six deaths linked to concomitant use of buprenorphine and benzodiazepines.

Authors:  M Reynaud; G Petit; D Potard; P Courty
Journal:  Addiction       Date:  1998-09       Impact factor: 6.526

10.  Metabolic interactions between opiates and alcohol.

Authors:  M J Kreek
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

View more
  80 in total

1.  Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.

Authors:  Yan Chang; Wenfang B Fang; Shen-Nan Lin; David E Moody
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-09-02       Impact factor: 4.080

2.  Outpatient Prescription Opioid Use in Pediatric Medicaid Enrollees With Special Health Care Needs.

Authors:  James A Feinstein; Jonathan Rodean; Matt Hall; Stephanie K Doupnik; James C Gay; Jessica L Markham; Jessica L Bettenhausen; Julia Simmons; Brigid Garrity; Jay G Berry
Journal:  Pediatrics       Date:  2019-06       Impact factor: 7.124

3.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

4.  Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A).

Authors:  Evan D Kharasch; Pamela Sheffels Bedynek; Christine Hoffer; Alysa Walker; Dale Whittington
Journal:  Anesthesiology       Date:  2012-02       Impact factor: 7.892

5.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Michael I Fingerhood; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

6.  Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury.

Authors:  Charles E Leonard; Colleen M Brensinger; Thanh Phuong Pham Nguyen; John R Horn; Sophie Chung; Warren B Bilker; Sascha Dublin; Samantha E Soprano; Ghadeer K Dawwas; David W Oslin; Douglas J Wiebe; Sean Hennessy
Journal:  Biomed Pharmacother       Date:  2020-07-30       Impact factor: 6.529

7.  Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV.

Authors:  William C Becker; Kirsha Gordon; E Jennifer Edelman; Robert D Kerns; Stephen Crystal; James D Dziura; Lynn E Fiellin; Adam J Gordon; Joseph L Goulet; Amy C Justice; David A Fiellin
Journal:  AIDS Behav       Date:  2016-03

Review 8.  Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.

Authors:  Jean Bonhomme; Ruth S Shim; Richard Gooden; Dawn Tyus; George Rust
Journal:  J Natl Med Assoc       Date:  2012 Jul-Aug       Impact factor: 1.798

9.  Factors associated with concurrent heroin use among patients on methadone maintenance treatment in Vietnam: A 24-month retrospective analysis of a nationally representative sample.

Authors:  Thai Hoang; Hong Nguyen; Ray W Shiraishi; Mai Nguyen; Trista Bingham; Diep Nguyen; Tam Nguyen; Hao Duong; Sheryl Lyss; Hien Tran
Journal:  Int J Drug Policy       Date:  2018-03-20

10.  Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings.

Authors:  Sean M Murphy; Dana Dweik; Sterling McPherson; John M Roll
Journal:  Am J Drug Alcohol Abuse       Date:  2015-01       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.